New York, New York–(Newsfile Corp. – May 3, 2022) – The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Homology Medicines, Inc. (NASDAQ: FIXX).Shareholders who purchased shares of FIXX during the class period listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/homology-medicines-inc-loss-submission-form/?id=26686&from=5
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Homology Medicines, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 24, 2022 – (FIXX)